Tag: Botensilimab

Neoadjuvant combined immunotherapy also effective in MSS/pMRR CRC

Presented By
Dr Mehraneh Jafari, Weill Cornell Medical Center, NY, USA
Trial
Phase 2, NEST-1
Conference
ESMO GI 2024
Type
Peer-reviewed article

21 August 2024 11:25

Combination botensilimab plus balstilimab demonstrates promising activity in heavily pre-treated MSS CRC

Presented By
Prof. Anthony El-Khoueiry, Norris Comprehensive Cancer Center, CA, USA
Trial
Phase 1, C-800
Conference
ASCO GI 2023
Type
Peer-reviewed article

17 March 2023 09:06
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com